Journal of Dairy Science
Volume 92, Issue 9 , Pages 4180-4187 , September 2009

Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors α and δ and retinoid X receptor α involved in the regulation of energy homeostasis, obesity, and inflammation

  • W. Suhara

      Affiliations

    • Institute Oncorex Inc., Sapporo, Hokkaido 060-0063, Japan
    • ,
  • H. Koide

      Affiliations

    • Institute Oncorex Inc., Sapporo, Hokkaido 060-0063, Japan
    • Theravalues Corporation, Tokyo 102-0094, Japan
    • ,
  • T. Okuzawa

      Affiliations

    • Institute Oncorex Inc., Sapporo, Hokkaido 060-0063, Japan
    • ,
  • D. Hayashi

      Affiliations

    • Theravalues Corporation, Tokyo 102-0094, Japan
    • ,
  • T. Hashimoto

      Affiliations

    • Theravalues Corporation, Tokyo 102-0094, Japan
    • ,
  • H. Kojo

      Affiliations

    • Institute Oncorex Inc., Sapporo, Hokkaido 060-0063, Japan
    • Theravalues Corporation, Tokyo 102-0094, Japan
    • Corresponding Author InformationCorresponding author.

Received 5 March 2009 ,Accepted 2 June 2009.

References 

  1. Bonjour JP, Brandolini-Bunlon M, Boirie Y, Morel-Laporte F, Braesco V, Bertière MC, et al. Inhibition of bone turnover by milk intake in postmenopausal women. Br. J. Nutr. 2008;100:866–874
  2. Bragt MC, Popeijus HE. Peroxisome proliferator-activated receptors and the metabolic syndrome. Physiol. Behav. 2008;94:187–197
  3. Cubero J, Narciso D, Aparicio S, Garau C, Valero V, Rivero M, et al. Improved circadian sleep-wake cycle in infants fed a day/night dissociated formula milk. Neuroendocrinol. Lett. 2006;27:373–380
  4. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 1996;384:39–43
  5. Feige JN, Gelman L, Tudor C, Engelborghs Y, Wahli W, Desvergne B. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem. 2005;280:17880–17890
  6. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from milk proteins. J. Nutr. 2004;134:980S–988S
  7. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 1995;81:541–550
  8. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 2006;58:760–772
  9. Grimaldi PA. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Cell. Mol. Life Sci. 2007;64:2459–2464
  10. Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci. 2004;66:149–154
  11. Huang TH, Kota BP, Razmovski V, Roufogalis BD. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin. Pharmacol. Toxicol. 2005;96:3–14
  12. Huth PJ, DiRienzo DB, Miller GD. Major scientific advances with dairy foods in nutrition and health. J. Dairy Sci. 2006;89:1207–1221
  13. Jauhiainen T, Korpela R. Milk peptides and blood pressure. J. Nutr. 2007;137:825S–829S
  14. Jiang Q, Heneka M, Landreth GE. The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: Therapeutic implications. CNS Drugs. 2008;22:1–14
  15. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992;358:771–774
  16. Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J. Nutr. 2003;133:261S–267S
  17. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting ot the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 2006;116:571–580
  18. Michalik L, Auwerx J, Berger JP, Chatterjee K, Glass CK, Gonzalez FJ, et al. International union of pharmacology.LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 2006;58:726–741
  19. Michalik L, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors and cancers: Complex stories. Nat. Rev. Cancer. 2004;4:61–70
  20. Mukherjee R, Jow L, Croston GE, Paterniti JR. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 1997;272:8071–8076
  21. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, et al. Ligand binding and co-activator assembly of the peroxisome-activated receptor-gamma. Nature. 1998;395:137–143
  22. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog. Lipid Res. 2001;40:283–298
  23. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes. Rev. 2007;8:109–118
  24. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 1992;6:1634–1641
  25. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am. J. Clin. Nutr. 2000;71:614S–620S
  26. Sher T, Yi HF, McBride OW, Gonzalez FJ. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 1993;32:5598–5604
  27. Soyeurt H, Dardenne P, Dehareng F, Lognay G, Veselko D, Marlier M, et al. Estimating fatty acid content in cow milk using mid-infrared spectrometry. J. Dairy Sci. 2006;89:3690–3695
  28. Sun X, Zemel MB. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J. Nutr. 2004;134:3054–3060
  29. Tachibana K, Yamasaki D, Ishimoto K, Doi T. The role of PPARs in cancer. PPAR Res. 2008;2008:102737
  30. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M, et al. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev. 2001;15:3263–3277
  31. Vanden-Heuvel JP, Thompson JT, Frame SR, Gillies PJ. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: A comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol. Sci. 2006;92:476–489
  32. Walczak R, Tontonoz P. PPARadigms and PPARadoxes: Expanding roles for PPARγ in the control of lipid metabolism. J. Lipid Res. 2002;43:177–186
  33. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003;113:159–170
  34. Wolf G. The function of the nuclear receptor peroxisome proliferator-activated receptor delta in energy homeostasis. Nutr. Rev. 2003;61:387–390

PII: S0022-0302(09)70742-8

doi: 10.3168/jds.2009-2186

Journal of Dairy Science
Volume 92, Issue 9 , Pages 4180-4187 , September 2009

Article Tools

* Image Usage & Resolution